Sustained headache freedom was achieved in 4 % ( 95 % CI : 0 % , 7 % ) of those randomized to valproate , 11 % ( 95 % CI : 5 % , 17 % ) of metoclopramide patients , and 16 % ( 95 % CI : 9 % , 23 % ) receiving ketorolac .